We found that PRKCB, PRKCH, and PRKCQ levels were directly associated with HLAs scores in almost most cancers, especially for PRKCB, whose elevated expression moderately to strongly controlled the HLA level in 28 cancer types (R ˃ 0.3) (Figure 8A). Here, PRKCB is linked to cancer.